BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9921911)

  • 1. Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Siebert R; Harder S; Theile M; Scherneck S; Schlegelberger B
    Hum Genet; 1998 Dec; 103(6):727-9. PubMed ID: 9921911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
    Zhang Y; Zhou J; Weng L; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Harder S; Siebert R; Castoldi G; Calasanz MJ; Wong KF; Rosenwald A; Ott G; Atkin NB; Schlegelberger B
    Genes Chromosomes Cancer; 2000 Jan; 27(1):52-8. PubMed ID: 10564586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia.
    Stilgenbauer S; Bullinger L; Benner A; Wildenberger K; Bentz M; Döhner K; Ho AD; Lichter P; Döhner H
    Leukemia; 1999 Sep; 13(9):1331-4. PubMed ID: 10482982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
    Dalsass A; Mestichelli F; Ruggieri M; Gaspari P; Pezzoni V; Vagnoni D; Angelini M; Angelini S; Bigazzi C; Falcioni S; Troiani E; Alesiani F; Catarini M; Attolico I; Scortechini I; Discepoli G; Galieni P
    Eur J Haematol; 2013 Jul; 91(1):10-9. PubMed ID: 23560441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma.
    Ohshima K; Haraokaa S; Ishihara S; Ohgami A; Yoshioka S; Suzumiya J; Kikuchi M
    Leuk Lymphoma; 2002 Feb; 43(2):293-300. PubMed ID: 11999560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection.
    Guan XY; Zhang HE; Zhou H; Sham JS; Fung JM; Trent JM
    Cancer Genet Cytogenet; 2002 Apr; 134(1):65-70. PubMed ID: 11996799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a dual-color fluorescence in situ hybridization probe set on chromosome 6q to improve cytogenetic diagnosis of lymphoid malignancies.
    Crowley JA; Butler MS; Ronnenburg MJ; Ament CN; Meekins JS; Ning Y
    Cancer Genet Cytogenet; 2005 Feb; 157(1):78-81. PubMed ID: 15676153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization.
    Amiel A; Mulchanov I; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Jul; 112(1):53-6. PubMed ID: 10432937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At least five regions of imbalance on 6q in breast tumors, combining losses and gains.
    Rodriguez C; Causse A; Ursule E; Theillet C
    Genes Chromosomes Cancer; 2000 Jan; 27(1):76-84. PubMed ID: 10564589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
    Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
    Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.
    Sinclair PB; Sorour A; Martineau M; Harrison CJ; Mitchell WA; O'Neill E; Foroni L
    Cancer Res; 2004 Jun; 64(12):4089-98. PubMed ID: 15205317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Jpn J Cancer Res; 2000 Mar; 91(3):293-300. PubMed ID: 10760688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma.
    Carvalho B; van der Veen A; Gärtner F; Carneiro F; Seruca R; Buys CH; Kok K
    Cancer Genet Cytogenet; 2001 Nov; 131(1):54-9. PubMed ID: 11734319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early involvement of 6q in surface epithelial ovarian tumors.
    Tibiletti MG; Bernasconi B; Furlan D; Riva C; Trubia M; Buraggi G; Franchi M; Bolis P; Mariani A; Frigerio L; Capella C; Taramelli R
    Cancer Res; 1996 Oct; 56(19):4493-8. PubMed ID: 8813146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines.
    Zhang Y; Siebert R; Matthiesen P; Harder S; Theile M; Scherneck S; Schlegelberger B
    Virchows Arch; 2000 Mar; 436(3):271-5. PubMed ID: 10782886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
    Acevedo CM; Henríquez M; Emmert-Buck MR; Chuaqui RF
    Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization analysis using cosmid probes to define chromosome 6q abnormalities in ovarian carcinoma cell lines.
    Lastowska MA; Lillington DM; Shelling AN; Cooke I; Gibbons B; Young BD; Ganesan TS
    Cancer Genet Cytogenet; 1994 Oct; 77(2):99-105. PubMed ID: 7954328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.